1012 / 1851
Dutch Phase II trial “RADITUX”:
Concurrent CT/RT using a hypofractionated scheme
To investigate 60-month OS in LA-NSCLC patients treated in Raditux
trial: concurrent chemoradiotherapy +/- cetuximab,
using a hypofractionation scheme of 24 x 2.75 Gy
RT schedule: 24 x 2.75 Gy
CT schedule: daily low
dose cisplatin (6 mg/m
2
)
+/- weekly cetuximab